Magazine Article | January 22, 2014

Risk Management: Controlling Supply Chain & Process Risk In Biomanufacturing

Request Information

Ensuring patients receive the lifesaving pharmaceuticals they need, when they need them is of paramount importance to any biopharmaceutical manufacturer. With the industry still at a relatively early stage of its development, few molecules if any are manufactured at a large number of global locations.

Biomanufacturers need to put into place all kinds of strategies to mitigate risk and ensure their products are available for patients. Imagine the scenario whereby an insulin production facility is forced to shut down or production was to cease limiting the availability of insulin to diabetics around the world. Of secondary importance, though still to be considered, is the resulting loss of sales for the manufacturer and a resultant drop in share price.

For full access to this content, please Register or Sign In.

Access Content Risk Management: Controlling Supply Chain & Process Risk In Biomanufacturing

Parker domnick hunter Process Filtration

Newsletter Signup
Newsletter Signup